Alvotech (ALVO)
USD 8.53
(-2.96%)
USD 8.53
(-2.96%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -69.42 Million USD | -466.65% |
| 2022 | 18.93 Million USD | -48.51% |
| 2021 | 36.77 Million USD | -44.8% |
| 2020 | 66.61 Million USD | 108.71% |
| 2019 | 31.91 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -7.52 Million USD | -148.5% |
| 2024 Q2 | 8.27 Million USD | 2139.9% |
| 2023 Q2 | -24.42 Million USD | -5.13% |
| 2023 Q1 | -23.23 Million USD | -376.53% |
| 2023 FY | -69.42 Million USD | -466.65% |
| 2023 Q3 | -18.73 Million USD | 23.27% |
| 2023 Q4 | -3.02 Million USD | 83.84% |
| 2022 Q1 | -1.29 Million USD | -103.73% |
| 2022 FY | 18.93 Million USD | -48.51% |
| 2022 Q4 | -4.87 Million USD | -424.14% |
| 2022 Q3 | 1.5 Million USD | -93.63% |
| 2022 Q2 | 23.6 Million USD | 1921.06% |
| 2021 FY | 36.77 Million USD | -44.8% |
| 2021 Q2 | 1.17 Million USD | 0.0% |
| 2021 Q3 | 536 Thousand USD | -54.5% |
| 2021 Q4 | 34.76 Million USD | 6385.82% |
| 2021 Q1 | 1.17 Million USD | -92.93% |
| 2020 FY | 66.61 Million USD | 108.71% |
| 2020 Q4 | 16.65 Million USD | 0.0% |
| 2020 Q3 | 16.65 Million USD | 0.0% |
| 2020 Q2 | 16.65 Million USD | 0.0% |
| 2020 Q1 | 16.65 Million USD | 108.71% |
| 2019 Q1 | 7.97 Million USD | 0.0% |
| 2019 Q2 | 7.97 Million USD | 0.0% |
| 2019 Q3 | 7.97 Million USD | 0.0% |
| 2019 Q4 | 7.97 Million USD | 0.0% |
| 2019 FY | 31.91 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 121.284% |
| Embecta Corp. | 749.9 Million USD | 109.258% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 122.739% |
| Dynavax Technologies Corporation | 182.11 Million USD | 138.119% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 195.011% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 114.159% |
| PainReform Ltd. | -15 Thousand USD | -462713.333% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 333.336% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 932.481% |
| SCYNEXIS, Inc. | 124.51 Million USD | 155.753% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | 12631.703% |
| Cosmos Health Inc. | 4.34 Million USD | 1696.066% |
| Journey Medical Corporation | 52.52 Million USD | 232.18% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 932.481% |
| Safety Shot Inc | -74.45 Thousand USD | -93137.708% |
| Alpha Teknova, Inc. | 10.29 Million USD | 774.262% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 116.121% |
| Bright Green Corporation | -237.01 Thousand USD | -29190.006% |
| Procaps Group, S.A. | 239.56 Million USD | 128.978% |
| Theratechnologies Inc. | 62.12 Million USD | 211.738% |
| Harrow Health, Inc. | 90.55 Million USD | 176.664% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | 1563.056% |
| Biofrontera Inc. | 16.62 Million USD | 517.526% |
| DURECT Corporation | 6.83 Million USD | 1116.279% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 113.255% |
| Cronos Group Inc. | 6.99 Million USD | 1093.034% |
| OptiNose, Inc. | 62.35 Million USD | 211.335% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 115.736% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | -22811.551% |
| RedHill Biopharma Ltd. | 3.05 Million USD | 2373.021% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 122.409% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | 1386.899% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 307.317% |
| Radius Health, Inc. | 307.71 Million USD | 122.561% |
| Universe Pharmaceuticals INC | 10.07 Million USD | 788.855% |
| ProPhase Labs, Inc. | 16.23 Million USD | 527.502% |
| Phibro Animal Health Corporation | 312.48 Million USD | 122.216% |
| Procaps Group S.A. | 239.56 Million USD | 128.978% |
| TherapeuticsMD, Inc. | 1.3 Million USD | 5431.951% |
| Viatris Inc. | 6.43 Billion USD | 101.078% |
| Rockwell Medical, Inc. | 8.7 Million USD | 897.587% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 227.179% |
| SIGA Technologies, Inc. | 122.09 Million USD | 156.86% |
| Tilray Brands, Inc. | 223.35 Million USD | 131.082% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 265.883% |
| Shineco, Inc. | 882.16 Thousand USD | 7969.476% |
| PetIQ, Inc. | 252.74 Million USD | 127.468% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | -9211.04% |
| Incannex Healthcare Limited | 12 Thousand USD | 578616.667% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 103.758% |
| Alimera Sciences, Inc. | 61.17 Million USD | 213.49% |
| Silver Spike Investment Corp. | 8.1 Million USD | 956.787% |
| Assertio Holdings, Inc. | 125.04 Million USD | 155.516% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | -1019162.957% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | 1756.388% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | 1158.908% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | -2780.371% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 356.009% |
| Hempacco Co., Inc. | -1.21 Million USD | -5609.83% |
| Talphera, Inc. | -4.89 Million USD | -1318.223% |
| Alvotech | -69.42 Million USD | -0.0% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 131.317% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 109.784% |
| Currenc Group, Inc. | 17.35 Million USD | 499.981% |
| Kamada Ltd. | 52.59 Million USD | 231.999% |
| Indivior PLC | 907 Million USD | 107.654% |
| Evoke Pharma, Inc. | 4.97 Million USD | 1494.366% |
| Flora Growth Corp. | 17.73 Million USD | 491.374% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | -2780.371% |
| Evolus, Inc. | 140.52 Million USD | 149.402% |
| HUTCHMED (China) Limited | 453.55 Million USD | 115.306% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 120.183% |
| Akanda Corp. | 111.44 Thousand USD | 62390.375% |